Begin main content

Search

We found 6637 result(s)

2020 CADTH Symposium

Event Date: April 19, 2020 - April 21, 2020
Result type: Events

Join us in Toronto for the 2020 CADTH Symposium. Connect with Canadian and international experts in the objective assessment and evaluation of health technologies for three days of education, information sharing, and networking. Mark your calendar: 2020 CADTH Symposium
April 19 to 21, 2020
Sheraton Centre Toronto
Toronto, On...

cabotegravir/rilpivirine (TBC)

Last Updated: December 4, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: cabotegravir-rilpivirine cabotegravir sodium
Indications: HIV-1 infection

  • Brand Name: TBC
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0628-000
  • Project Status: Active
  • Submission Type: New Combination

dupilumab (Dupixent)

Last Updated: December 5, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: dupilumab
Indications: atopic dermatitis

  • Brand Name: Dupixent
  • Manufacturer: Sanofi Genzyme, a division of sanofi-aventis Canada Inc.
  • Project Number: SR0636-000
  • Project Status: Active
  • Submission Type: New

certolizumab pegol (Cimzia)

Last Updated: December 5, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: certolizumab pegol
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: Cimzia
  • Manufacturer: UCB Canada Inc.
  • Project Number: SR0587-000
  • Project Status: Active
  • Submission Type: New Indication

cyclosporine (Verkazia)

Last Updated: December 4, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: cyclosporine
Indications: Severe vernal keratoconjunctivitis, pediatric (≥4 years)

  • Brand Name: Verkazia
  • Manufacturer: Santen Canada Inc.
  • Project Number: SR0615-000
  • Project Status: Active
  • Submission Type: New

brolucizumab (TBC)

Last Updated: December 5, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: brolucizumab
Indications: Macular degeneration, age-related

  • Brand Name: TBC
  • Manufacturer: Novartis Pharmaceuticals Canada Inc.
  • Project Number: SR0632-000
  • Project Status: Active
  • Submission Type: New